A Randomized Double-Blind Comparison of Coformulated Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Disoproxil Fumarate Versus Efavirenz/Emtricitabine/Tenofovir Disoproxil Fumarate for Initial Treatment of HIV-1 Infection

Andrew Zolopa; Paul E. Sax; Edwin DeJesus; Anthony Mills; Calvin Cohen; David Wohl; Joel E. Gallant; Hui C. Liu; Andrew Plummer; Kirsten L. White; Andrew K. Cheng; Martin S. Rhee; Javier Szwarcberg

doi:10.1097/qai.0b013e318289545c

A Randomized Double-Blind Comparison of Coformulated Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Disoproxil Fumarate Versus Efavirenz/Emtricitabine/Tenofovir Disoproxil Fumarate for Initial Treatment of HIV-1 Infection

JAIDS Journal of Acquired Immune Deficiency Syndromes ◽

10.1097/qai.0b013e318289545c ◽

2013 ◽

Vol 63 (1) ◽

pp. 96-100 ◽

Cited By ~ 100

Author(s):

Andrew Zolopa ◽

Paul E. Sax ◽

Edwin DeJesus ◽

Anthony Mills ◽

Calvin Cohen ◽

...

Keyword(s):

Tenofovir Disoproxil Fumarate ◽

Initial Treatment ◽

Double Blind ◽

Blind Comparison ◽

Hiv 1

Download Full-text

Faculty Opinions recommendation of Co-formulated elvitegravir, cobicistat, emtricitabine, and tenofovir disoproxil fumarate versus ritonavir-boosted atazanavir plus co-formulated emtricitabine and tenofovir disoproxil fumarate for initial treatment of HIV-1 infection: a randomised, double-blind, phase 3, non-inferiority trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.717954439.793460355 ◽

2012 ◽

Author(s):

Kiat Ruxrungtham ◽

Wirach Maek-a-nantawat

Keyword(s):

Tenofovir Disoproxil Fumarate ◽

Initial Treatment ◽

Phase 3 ◽

Double Blind ◽

Hiv 1

Download Full-text

A Randomized, Double-Blind Comparison of Coformulated Elvitegravir/Cobicistat/Emtricitabine/Tenofovir DF vs Ritonavir-Boosted Atazanavir Plus Coformulated Emtricitabine and Tenofovir DF for Initial Treatment of HIV-1 Infection

JAIDS Journal of Acquired Immune Deficiency Syndromes ◽

10.1097/qai.0b013e3182a1fe0f ◽

2013 ◽

Vol 63 (5) ◽

pp. e171 ◽

Cited By ~ 1

Author(s):

&NA;

Keyword(s):

Initial Treatment ◽

Double Blind ◽

Tenofovir Df ◽

Blind Comparison ◽

Hiv 1

Download Full-text

A Randomized, Double-blind Comparison of Single-Tablet Regimen Elvitegravir/Cobicistat/Emtricitabine/Tenofovir DF vs Ritonavir-Boosted Atazanavir Plus Emtricitabine/Tenofovir DF for Initial Treatment of HIV-1 Infection

JAIDS Journal of Acquired Immune Deficiency Syndromes ◽

10.1097/qai.0000000000000089 ◽

2014 ◽

Vol 65 (3) ◽

pp. e121-e124 ◽

Cited By ~ 58

Author(s):

Nathan Clumeck ◽

Jean-Michel Molina ◽

Keith Henry ◽

Joseph Gathe ◽

Jürgen K. Rockstroh ◽

...

Keyword(s):

Initial Treatment ◽

Double Blind ◽

Single Tablet Regimen ◽

Tenofovir Df ◽

Blind Comparison ◽

Hiv 1

Download Full-text

Co-formulated elvitegravir, cobicistat, emtricitabine, and tenofovir disoproxil fumarate versus ritonavir-boosted atazanavir plus co-formulated emtricitabine and tenofovir disoproxil fumarate for initial treatment of HIV-1 infection: a randomised, double-blind, phase 3, non-inferiority trial

The Lancet ◽

10.1016/s0140-6736(12)60918-0 ◽

2012 ◽

Vol 379 (9835) ◽

pp. 2429-2438 ◽

Cited By ~ 245

Author(s):

Edwin DeJesus ◽

Jürgen K Rockstroh ◽

Keith Henry ◽

Jean-Michel Molina ◽

Joseph Gathe ◽

...

Keyword(s):

Tenofovir Disoproxil Fumarate ◽

Initial Treatment ◽

Phase 3 ◽

Double Blind ◽

Hiv 1

Download Full-text

A Randomized, Double-Blind Comparison of Coformulated Elvitegravir/Cobicistat/Emtricitabine/Tenofovir DF vs Ritonavir-Boosted Atazanavir Plus Coformulated Emtricitabine and Tenofovir DF for Initial Treatment of HIV-1 Infection

JAIDS Journal of Acquired Immune Deficiency Syndromes ◽

10.1097/qai.0b013e318286415c ◽

2013 ◽

Vol 62 (5) ◽

pp. 483-486 ◽

Cited By ~ 81

Author(s):

Jürgen K. Rockstroh ◽

Edwin DeJesus ◽

Keith Henry ◽

Jean-Michel Molina ◽

Joseph Gathe ◽

...

Keyword(s):

Initial Treatment ◽

Double Blind ◽

Tenofovir Df ◽

Blind Comparison ◽

Hiv 1

Download Full-text

Tenofovir alafenamide versus tenofovir disoproxil fumarate, coformulated with elvitegravir, cobicistat, and emtricitabine, for initial treatment of HIV-1 infection: two randomised, double-blind, phase 3, non-inferiority trials

The Lancet ◽

10.1016/s0140-6736(15)60616-x ◽

2015 ◽

Vol 385 (9987) ◽

pp. 2606-2615 ◽

Cited By ~ 334

Author(s):

Paul E Sax ◽

David Wohl ◽

Michael T Yin ◽

Frank Post ◽

Edwin DeJesus ◽

...

Keyword(s):

Tenofovir Disoproxil Fumarate ◽

Initial Treatment ◽

Phase 3 ◽

Double Blind ◽

Tenofovir Alafenamide ◽

Hiv 1

Download Full-text

A Randomized, Double-Blind Comparison of Single-Tablet Regimen Elvitegravir/Cobicistat/Emtricitabine/Tenofovir DF Versus Single-Tablet Regimen Efavirenz/Emtricitabine/Tenofovir DF for Initial Treatment of HIV-1 Infection

JAIDS Journal of Acquired Immune Deficiency Syndromes ◽

10.1097/qai.0000000000000057 ◽

2014 ◽

Vol 65 (3) ◽

pp. e118-e120 ◽

Cited By ~ 72

Author(s):

David A. Wohl ◽

Calvin Cohen ◽

Joel E. Gallant ◽

Anthony Mills ◽

Paul E. Sax ◽

...

Keyword(s):

Initial Treatment ◽

Double Blind ◽

Single Tablet Regimen ◽

Tenofovir Df ◽

Blind Comparison ◽

Hiv 1

Download Full-text

Faculty Opinions recommendation of Tenofovir alafenamide versus tenofovir disoproxil fumarate, coformulated with elvitegravir, cobicistat, and emtricitabine, for initial treatment of HIV-1 infection: two randomised, double-blind, phase 3, non-inferiority trials.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.725442708.793509558 ◽

2015 ◽

Author(s):

Anthony Harries

Keyword(s):

Tenofovir Disoproxil Fumarate ◽

Initial Treatment ◽

Phase 3 ◽

Double Blind ◽

Tenofovir Alafenamide ◽

Hiv 1

Download Full-text

Longer-Term Safety and Efficacy of Emtricitabine and Tenofovir Alafenamide Versus Emtricitabine and Tenofovir Disoproxil Fumarate for HIV-1 Pre-Exposure Prophylaxis: Week 96 Results from a Randomized, Double-Blind, Placebo-Controlled Phase 3 Trial

SSRN Electronic Journal ◽

10.2139/ssrn.3772801 ◽

2021 ◽

Author(s):

Onyema Ogbuagu ◽

Peter J. Ruane ◽

Daniel Podzamczer ◽

Laura C. Salazar ◽

Keith Henry ◽

...

Keyword(s):

Tenofovir Disoproxil Fumarate ◽

Phase 3 ◽

Double Blind ◽

Safety And Efficacy ◽

Double Blind Placebo ◽

Tenofovir Alafenamide ◽

Exposure Prophylaxis ◽

Hiv 1

Download Full-text

Coformulated bictegravir, emtricitabine, and tenofovir alafenamide versus dolutegravir with emtricitabine and tenofovir alafenamide, for initial treatment of HIV-1 infection (GS-US-380–1490): a randomised, double-blind, multicentre, phase 3, non-inferiority trial

The Lancet ◽

10.1016/s0140-6736(17)32340-1 ◽

2017 ◽

Vol 390 (10107) ◽

pp. 2073-2082 ◽

Cited By ~ 97

Author(s):

Paul E Sax ◽

Anton Pozniak ◽

M Luisa Montes ◽

Ellen Koenig ◽

Edwin DeJesus ◽

...

Keyword(s):

Initial Treatment ◽

Phase 3 ◽

Double Blind ◽

Multicentre Phase ◽

Tenofovir Alafenamide ◽

Hiv 1

Download Full-text